共 119 条
[1]
Galle PR(2019)Biology and significance of alpha-fetoprotein in hepatocellular carcinoma Liver Int 39 2214-29
[2]
Foerster F(2009)New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy J Clin Oncol 27 446-52
[3]
Kudo M(2009)Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma Oncologist 14 717-25
[4]
Chan SL(2010)Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma Cancer 116 4590-6
[5]
Llovet JM(2018)Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review J Formos Med Assoc 117 153-63
[6]
Qin S(2019)Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Liver Int 39 2184-89
[7]
Chan SL(2020)Serum alpha-fetoprotein levels and clinical outcomes in the phase III CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma Clin Cancer Res 26 4795-804
[8]
Mo FK(2020)Predictors of response and survival in immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma Cancers (Basel) 12 182-97
[9]
Johnson PJ(2021)Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab Br J Cancer 124 1388-8
[10]
Hui EP(2023)Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment Cancer Med 12 2731-402